0.6923
price down icon41.82%   -0.4977
 
loading

Bioatla Inc Aktie (BCAB) Neueste Nachrichten

pulisher
Dec 21, 2024

BioAtla Announces Registered Direct Offering to Advance Clinical Programs to Key Inflection PointsSan Diego, Calif., December 20, 2024 – BioAtla, Inc. (NASDAQ: BCAB), a global clinical-stage biotechnology company, disclosed on December 19, 2024, that - Defense World

Dec 21, 2024
pulisher
Dec 20, 2024

BioAtla Secures $9.2M for Clinical Program Advancements - TipRanks

Dec 20, 2024
pulisher
Dec 20, 2024

Bioatla stock hits 52-week low at $1.02 amid market challenges - Investing.com

Dec 20, 2024
pulisher
Dec 20, 2024

BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points - The Manila Times

Dec 20, 2024
pulisher
Dec 20, 2024

BioAtla Highlights Advancements in CAB Cancer Therapy - TipRanks

Dec 20, 2024
pulisher
Dec 20, 2024

BioAtla announces $9.2 million stock and warrant sale - Investing.com

Dec 20, 2024
pulisher
Dec 20, 2024

BioAtla announces registered direct offering to advance two mid-stage clinical programs, shares fall - Seeking Alpha

Dec 20, 2024
pulisher
Dec 20, 2024

BioAtla Secures $9.2M Funding Through Strategic Stock Offering to Advance Clinical Programs - StockTitan

Dec 20, 2024
pulisher
Dec 18, 2024

Insiders Give Up US$66k As BioAtla Stock Drops To US$1.31 - Yahoo Finance

Dec 18, 2024
pulisher
Dec 16, 2024

BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting - The Manila Times

Dec 16, 2024
pulisher
Dec 15, 2024

BioAtla's SWOT analysis: oncology biotech stock faces pivotal year - Investing.com

Dec 15, 2024
pulisher
Dec 10, 2024

BioAtla Announces Upcoming Poster Presentation at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting - Quantisnow

Dec 10, 2024
pulisher
Nov 21, 2024

BioAtla's SWOT analysis: oncology biotech stock faces pivotal year By Investing.com - Investing.com Canada

Nov 21, 2024
pulisher
Nov 20, 2024

BioAtla, Inc. (NASDAQ:BCAB) Q3 2024 Earnings Call Transcript - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Michael Burry's Scion fund exits BioAtla, boosts Alibaba stake, adds puts: top Q3 trades - MSN

Nov 19, 2024
pulisher
Nov 19, 2024

GSA Capital Partners LLP Purchases New Position in BioAtla, Inc. (NASDAQ:BCAB) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

BioAtla, Inc. (NASDAQ:BCAB) Sees Significant Drop in Short Interest - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

HC Wainwright Weighs in on BioAtla FY2024 Earnings - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

FY2024 Earnings Estimate for BioAtla Issued By HC Wainwright - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Analysis of TANG CAPITAL MANAGEMENT LLC's Recent Transaction in BioAtla Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

BioAtla (NASDAQ:BCAB) Rating Lowered to Neutral at HC Wainwright - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

Michael Burry's Scion fund exits BioAtla, boosts Alibaba stake, adds puts: top Q3 trades (HPP:NYSE) - Seeking Alpha

Nov 14, 2024
pulisher
Nov 14, 2024

HC Wainwright & Co. Downgrades BioAtla (BCAB) - MSN

Nov 14, 2024
pulisher
Nov 13, 2024

BioAtla (NASDAQ:BCAB) Downgraded to "Neutral" Rating by HC Wainwright - MarketBeat

Nov 13, 2024
pulisher
Nov 09, 2024

BioAtla Inc (BCAB) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada

Nov 09, 2024
pulisher
Nov 09, 2024

Head to Head Review: Alector (NASDAQ:ALEC) vs. BioAtla (NASDAQ:BCAB) - Defense World

Nov 09, 2024
pulisher
Nov 08, 2024

3 Promising US Penny Stocks With At Least $90M Market Cap - Simply Wall St

Nov 08, 2024
pulisher
Nov 08, 2024

BioAtla Reports Q3 2024 Financial Results and Clinical Advances - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

BioAtla reports Q3 EPS (22c), consensus (36c) - TipRanks

Nov 07, 2024
pulisher
Nov 07, 2024

BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress - StockTitan

Nov 07, 2024
pulisher
Nov 01, 2024

BioAtla (BCAB) Scheduled to Post Earnings on Thursday - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

BioAtla to Announce Third Quarter 2024 Financial Results and Provide Business Highlights on November 7, 2024 - The Manila Times

Oct 31, 2024
pulisher
Oct 30, 2024

BioAtla, Inc. (NASDAQ:BCAB) has caught the attention of institutional investors who hold a sizeable 39% stake - Yahoo Finance UK

Oct 30, 2024
pulisher
Oct 28, 2024

BioAtla, Inc. (NASDAQ:BCAB) Short Interest Update - MarketBeat

Oct 28, 2024
pulisher
Oct 20, 2024

BioAtla, Inc. (BCAB): Among Michael Burry’s Top 10 Stock Picks Heading Into 2025 - Insider Monkey

Oct 20, 2024
pulisher
Oct 15, 2024

You might want to take a look at BioAtla Inc (BCAB) now - SETE News

Oct 15, 2024
pulisher
Oct 14, 2024

BioAtla Inc (BCAB) stock: A year of ups and downs - US Post News

Oct 14, 2024
pulisher
Oct 14, 2024

Market Insights: BioAtla Inc (BCAB)’s Notable Gain of 7.25, Closing at 2.07 - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

Michael Burry – Top 10 Holdings – Latest 13F - The Acquirer's Multiple

Oct 14, 2024
pulisher
Oct 13, 2024

636,136 Shares in BioAtla, Inc. (NASDAQ:BCAB) Acquired by AQR Capital Management LLC - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

AQR Capital Management LLC Makes New Investment in BioAtla, Inc. (NASDAQ:BCAB) - MarketBeat

Oct 13, 2024
pulisher
Oct 09, 2024

There is no doubt that BioAtla Inc (BCAB) ticks all the boxes. - SETE News

Oct 09, 2024
pulisher
Oct 09, 2024

Bank of Montreal Can Buys 143,521 Shares of BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Oct 09, 2024
pulisher
Oct 09, 2024

'Big Short' Investor Michael Burry's China Bet Pays Off As Top Picks Surge Nearly 60% In 2 Months - Benzinga

Oct 09, 2024
pulisher
Oct 08, 2024

BioAtla's FDA Fast-Tracked Drug Candidate Boosts Its Oncology Prospects, Speculative Buy - Seeking Alpha

Oct 08, 2024
pulisher
Oct 08, 2024

Renaissance Technologies LLC Sells 370,800 Shares of BioAtla, Inc. (NASDAQ:BCAB) - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

BioAtla: Numerous Catalysts Coming In Q4 (NASDAQ:BCAB) - Seeking Alpha

Oct 07, 2024
pulisher
Oct 07, 2024

Analyzing the Impact of Earnings Reports on BioAtla Inc Inc. (BCAB) Price Performance - The InvestChronicle

Oct 07, 2024
pulisher
Oct 07, 2024

BioAtla to Score Up to $133M - San Diego Business Journal

Oct 07, 2024
pulisher
Oct 07, 2024

Should investors be concerned about BioAtla Inc (BCAB)? - US Post News

Oct 07, 2024
pulisher
Oct 06, 2024

BioAtla to Host Virtual R&D Day on Clinical Program and Pipeline Updates on July 25, 2024 - Quantisnow

Oct 06, 2024
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):